首页> 外文期刊>The journal of clinical hypertension. >Identifiable hypertension: A new spectrum
【24h】

Identifiable hypertension: A new spectrum

机译:可识别的高血压:一个新领域

获取原文
获取原文并翻译 | 示例
           

摘要

Since the original description of hypertension as Bright's disease, there has been a distinction between high blood pressure related to an underlying condition and high blood pressure that occurs on its own: "secondary hypertension" and "primary or essential hypertension," respectively.1 In 2003, the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) introduced "identifiable hypertension," replacing "secondary hypertension."2 However, the implications of the two terms may not be exactly the same. "Secondary" suggests a specific pathologic and curable cause such as pheochromocytoma. However, "identifiable," as used in JNC 7, has a broader context that often includes found disorders strongly associated with hypertension with multiple causes. Each form of identifiable hypertension, even when not curable, can be linked to specific characteristics and strategies for management that go beyond the usual treatment of hypertension.
机译:自从最初将高血压描述为布莱特氏病以来,与潜在疾病相关的高血压与单独发生的高血压之间就存在区别:分别是“继发性高血压”和“原发性或原发性高血压”。1 2003年,全国预防,检测,评估和治疗高血压联合委员会的第七次报告(JNC 7)引入了“可识别的高血压”,代替了“继发性高血压”。2但是,这两个术语的含义可能并不相同。完全一样。 “次要”提示特定的病理和可治愈原因,例如嗜铬细胞瘤。但是,JNC 7中使用的“可识别的”具有更广泛的背景,通常包括已发现的与多种原因引起的高血压密切相关的疾病。每种可识别的高血压形式,即使无法治愈,也可以与超出常规高血压治疗方法的特定特征和治疗策略相关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号